Bermuda | 98-014-1974 |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification Number) |
Page | ||
ITEM 1. | ||
ITEM 2. | ||
ITEM 3. | ||
ITEM 4. | ||
ITEM 1. | ||
ITEM 1A. | ||
ITEM 2. | ||
ITEM 3. | ||
ITEM 4. | ||
ITEM 5. | ||
ITEM 6. | ||
• | we are exposed to significant losses from catastrophic events and other exposures that we cover, which we expect to cause significant volatility in our financial results from time to time; |
• | the inherent uncertainties in our reserving process, particularly as regards to large catastrophic events and longer tail casualty lines, the uncertainties of which we expect to increase as our product and geographical diversity increases; |
• | the frequency and severity of catastrophic and other events which we cover could exceed our estimates and cause losses greater than we expect; |
• | the risk of the lowering or loss of any of the financial strength, claims paying or enterprise wide risk management ratings of RenaissanceRe Holdings Ltd. (“RenaissanceRe”) or of one or more of our subsidiaries or joint ventures or changes in the policies or practices of the rating agencies; |
• | risks associated with appropriately modeling, pricing for, and contractually addressing new or potential factors in loss emergence, such as the trend toward potentially significant global warming and other aspects of climate change which have the potential to adversely affect our business, any of which could cause us to underestimate our exposures and potentially adversely impact our financial results; |
• | the risk we might be bound to policyholder obligations beyond our underwriting intent, or unable to enforce our own intent in respect of retrocessional arrangements, including in each case due to emerging claims and coverage issues; |
• | risks due to our increasing reliance on a small and decreasing number of reinsurance brokers and other distribution services for the preponderance of our revenue; |
• | risks relating to operating in a highly competitive environment, which we expect to continue to increase over time from new competition from traditional and non-traditional participants, particularly as capital markets products provide alternatives and replacements for more traditional reinsurance and insurance products, as new entrants or existing competitors attempt to replicate our business model, and as a result of consolidation in the (re)insurance industry; |
• | risks relating to deteriorating market conditions, including the risks of decreasing revenues, margins, capital efficiency and returns; |
• | the risk that our customers may fail to make premium payments due to us, as well as the risk of failures of our reinsurers, brokers or other counterparties to honor their obligations to us, including as regards to large catastrophic events, and also including their obligations to make third party payments for which we might be liable; |
• | a contention by the Internal Revenue Service that Renaissance Reinsurance Ltd. (“Renaissance Reinsurance”), or any of our other Bermuda subsidiaries, is subject to U.S. taxation; |
• | other risks relating to potential adverse tax developments, including potential changes to the taxation of inter-company or related party transactions, or potential changes to the tax treatment of investors in RenaissanceRe or our joint ventures or other entities we manage; |
• | risks relating to adverse legislative developments that could reduce the size of the private markets we serve, or impede their future growth, including proposals to shift United States (“U.S.”) catastrophe risks to federal mechanisms; similar proposals at the state level in the U.S., including the risk of legislation in Florida to expand the reinsurance coverage offered by the Florida Hurricane Catastrophe Fund (“FHCF”) and the insurance policies written by Citizens Property Insurance Corporation (“Citizens”), or failing to implement reforms to reduce such coverage; risks of adverse legislation in relation to U.S. flood insurance or the failure to implement reform legislation; and the risk that new legislation will be enacted in the international markets we serve which might reduce market opportunities in the private sector, weaken our customers or otherwise adversely impact us; |
• | risks associated with our investment portfolio, including the risk that our investment assets may fail to yield attractive or even positive results; and the risk that investment managers may breach our investment guidelines, or the inability of such guidelines to mitigate investment risks; |
• | risks associated with implementing our business strategies and initiatives, including risks related to strategic transactions, developing or enhancing the operations, controls and other infrastructure necessary in respect of our more recent, new or proposed initiatives, and the risk that we may fail to succeed in our business or financing plans for these initiatives; |
• | risks that certain of our new or potentially expanding business lines could have a significant negative impact on our financial results or cause significant volatility in our results for any particular period; |
• | risks associated with potential for loss of services of any one of our key senior officers, the risk that we fail to attract or retain the executives and employees necessary to manage our business, and difficulties associated with the transition of members of our senior management team for new or expanded roles necessary to execute our strategic and tactical plans; |
• | risks relating to the inability, or delay, in the claims paying ability of Citizens, FHCF or of private market participants in Florida, particularly following a large windstorm or of multiple smaller storms, which we believe would weaken or destabilize the Florida market and give rise to an unpredictable range of impacts which might be adverse to us, perhaps materially so; |
• | risks associated with the management of our operations as our product and geographical diversity increases, including the potential inability to allocate sufficient resources to our strategic and tactical plans or to address additional industry or regulatory developments and requirements; |
• | changes in economic conditions, including interest rate, currency, equity and credit conditions which could affect our investment portfolio or declines in our investment returns for other reasons which could reduce our profitability and hinder our ability to pay claims promptly in accordance with our strategy, which risks we believe are currently enhanced in light of the current macroeconomic uncertainty and the recent period of relative economic weakness, both globally, particularly in respect of Eurozone countries and companies, and in the U.S.; |
• | risks associated with highly subjective judgments, such as valuing our more illiquid assets, and determining the impairments taken on our investments, all of which impact our reported financial position and operating results; |
• | risks associated with our retrocessional reinsurance protection, including the risks that the coverages and protections we seek may become unavailable or only available on unfavorable terms, that the forms of retrocessional protection available in the market on acceptable terms may give rise to more risk in our net portfolio than we find desirable or that we correctly identify, or that we are otherwise |
• | risks associated with inflation, which could cause loss costs to increase, and impact the performance of our investment portfolio, thereby adversely impacting our financial position or operating results; |
• | operational risks, including system or human failures, which risks could result in our incurring material losses; |
• | risks in connection with our management of capital on behalf of investors in joint ventures or other entities we manage, such as failing to comply with complex laws and regulations relating to the management of such capital or the potential rights of third party investors, which failure could result in our incurring significant liabilities, penalties or other losses; |
• | risks that we may require additional capital in the future, particularly after a catastrophic event or to support potential growth opportunities in our business, which may not be available or may be available only on unfavorable terms; |
• | risks relating to our potential failure to comply with covenants in our debt agreements, which failure could provide our lenders the right to accelerate our debt which would adversely impact us; |
• | the risk of potential challenges to the claim of exemption from insurance regulation of RenaissanceRe and certain of our subsidiaries in certain jurisdictions under certain current laws and the risk of increased global regulation of the insurance and reinsurance industry; |
• | risks relating to the inability of our operating subsidiaries to declare and pay dividends, which could cause us to be unable to pay dividends to our shareholders or to repay our indebtedness; |
• | the risk that there could be regulatory or legislative changes adversely impacting us, as a Bermuda-based company, relative to our competitors, or actions taken by multinational organizations having such an impact; |
• | risks arising out of possible changes in the distribution or placement of risks due to increased consolidation of customers or insurance and reinsurance brokers; and |
• | risks relating to changes in regulatory regimes and/or accounting rules, which could result in significant changes to our financial results, including but not limited to, the European Union directive concerning capital adequacy, risk management and regulatory reporting for insurers. |
September 30, 2014 | December 31, 2013 | ||||||
Assets | (Unaudited) | (Audited) | |||||
Fixed maturity investments trading, at fair value (Amortized cost $4,735,061 and $4,781,712 at September 30, 2014 and December 31, 2013, respectively) | $ | 4,750,766 | $ | 4,809,036 | |||
Fixed maturity investments available for sale, at fair value (Amortized cost $24,664 and $30,273 at September 30, 2014 and December 31, 2013, respectively) | 28,069 | 34,241 | |||||
Short term investments, at fair value | 1,031,143 | 1,044,779 | |||||
Equity investments trading, at fair value | 301,714 | 254,776 | |||||
Other investments, at fair value | 501,487 | 573,264 | |||||
Investments in other ventures, under equity method | 118,245 | 105,616 | |||||
Total investments | 6,731,424 | 6,821,712 | |||||
Cash and cash equivalents | 300,547 | 408,032 | |||||
Premiums receivable | 630,718 | 474,087 | |||||
Prepaid reinsurance premiums | 195,978 | 66,132 | |||||
Reinsurance recoverable | 79,043 | 101,025 | |||||
Accrued investment income | 25,514 | 34,065 | |||||
Deferred acquisition costs | 130,108 | 81,684 | |||||
Receivable for investments sold | 147,206 | 75,845 | |||||
Other assets | 108,443 | 108,438 | |||||
Goodwill and other intangible assets | 7,954 | 8,111 | |||||
Total assets | $ | 8,356,935 | $ | 8,179,131 | |||
Liabilities, Noncontrolling Interests and Shareholders’ Equity | |||||||
Liabilities | |||||||
Reserve for claims and claim expenses | $ | 1,532,780 | $ | 1,563,730 | |||
Unearned premiums | 758,272 | 477,888 | |||||
Debt | 249,499 | 249,430 | |||||
Reinsurance balances payable | 501,155 | 293,022 | |||||
Payable for investments purchased | 284,295 | 193,221 | |||||
Other liabilities | 203,908 | 397,596 | |||||
Total liabilities | 3,529,909 | 3,174,887 | |||||
Commitments and Contingencies | |||||||
Redeemable noncontrolling interest | 1,091,166 | 1,099,860 | |||||
Shareholders’ Equity | |||||||
Preference shares: $1.00 par value – 16,000,000 shares issued and outstanding at September 30, 2014 (December 31, 2013 – 16,000,000) | 400,000 | 400,000 | |||||
Common shares: $1.00 par value – 38,887,563 shares issued and outstanding at September 30, 2014 (December 31, 2013 – 43,646,436) | 38,888 | 43,646 | |||||
Accumulated other comprehensive income | 3,829 | 4,131 | |||||
Retained earnings | 3,293,143 | 3,456,607 | |||||
Total shareholders’ equity attributable to RenaissanceRe | 3,735,860 | 3,904,384 | |||||
Total liabilities, noncontrolling interests and shareholders’ equity | $ | 8,356,935 | $ | 8,179,131 |
Three months ended | Nine months ended | ||||||||||||||
September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | ||||||||||||
Revenues | |||||||||||||||
Gross premiums written | $ | 200,992 | $ | 182,649 | $ | 1,417,792 | $ | 1,521,290 | |||||||
Net premiums written | $ | 159,713 | $ | 127,241 | $ | 956,467 | $ | 1,123,163 | |||||||
Decrease (increase) in unearned premiums | 99,266 | 167,476 | (150,538 | ) | (265,302 | ) | |||||||||
Net premiums earned | 258,979 | 294,717 | 805,929 | 857,861 | |||||||||||
Net investment income | 24,941 | 59,931 | 98,430 | 129,296 | |||||||||||
Net foreign exchange gains | 5,036 | 488 | 6,367 | 170 | |||||||||||
Equity in earnings of other ventures | 9,806 | 7,313 | 21,237 | 16,920 | |||||||||||
Other (loss) income | (1,169 | ) | 651 | (1,642 | ) | (2,186 | ) | ||||||||
Net realized and unrealized (losses) gains on investments | (31,097 | ) | 28,472 | 10,958 | (26,788 | ) | |||||||||
Total revenues | 266,496 | 391,572 | 941,279 | 975,273 | |||||||||||
Expenses | |||||||||||||||
Net claims and claim expenses incurred | 69,647 | 60,928 | 209,950 | 192,141 | |||||||||||
Acquisition expenses | 37,550 | 37,699 | 104,727 | 94,475 | |||||||||||
Operational expenses | 46,972 | 44,672 | 135,437 | 133,447 | |||||||||||
Corporate expenses | 3,905 | 4,307 | 12,404 | 30,318 | |||||||||||
Interest expense | 4,290 | 4,298 | 12,875 | 13,632 | |||||||||||
Total expenses | 162,364 | 151,904 | 475,393 | 464,013 | |||||||||||
Income from continuing operations before taxes | 104,132 | 239,668 | 465,886 | 511,260 | |||||||||||
Income tax expense | (245 | ) | (223 | ) | (207 | ) | (356 | ) | |||||||
Income from continuing operations | 103,887 | 239,445 | 465,679 | 510,904 | |||||||||||
(Loss) income from discontinued operations | — | (9,779 | ) | — | 2,422 | ||||||||||
Net income | 103,887 | 229,666 | 465,679 | 513,326 | |||||||||||
Net income attributable to noncontrolling interests | (30,477 | ) | (44,331 | ) | (109,323 | ) | (96,953 | ) | |||||||
Net income attributable to RenaissanceRe | 73,410 | 185,335 | 356,356 | 416,373 | |||||||||||
Dividends on preference shares | (5,595 | ) | (5,595 | ) | (16,786 | ) | (19,353 | ) | |||||||
Net income available to RenaissanceRe common shareholders | $ | 67,815 | $ | 179,740 | $ | 339,570 | $ | 397,020 | |||||||
Income from continuing operations available to RenaissanceRe common shareholders per common share – basic | $ | 1.72 | $ | 4.32 | $ | 8.38 | $ | 8.95 | |||||||
(Loss) income from discontinued operations (attributable) available to RenaissanceRe common shareholders per common share – basic | — | (0.23 | ) | — | 0.06 | ||||||||||
Net income available to RenaissanceRe common shareholders per common share – basic | $ | 1.72 | $ | 4.09 | $ | 8.38 | $ | 9.01 | |||||||
Income from continuing operations available to RenaissanceRe common shareholders per common share – diluted | $ | 1.70 | $ | 4.23 | $ | 8.26 | $ | 8.79 | |||||||
(Loss) income from discontinued operations (attributable) available to RenaissanceRe common shareholders per common share – diluted | — | (0.22 | ) | — | 0.05 | ||||||||||
Net income available to RenaissanceRe common shareholders per common share – diluted | $ | 1.70 | $ | 4.01 | $ | 8.26 | $ | 8.84 | |||||||
Dividends per common share | $ | 0.29 | $ | 0.28 | $ | 0.87 | $ | 0.84 |
Three months ended | Nine months ended | ||||||||||||||
September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | ||||||||||||
Comprehensive income | |||||||||||||||
Net income | $ | 103,887 | $ | 229,666 | $ | 465,679 | $ | 513,326 | |||||||
Change in net unrealized gains on investments | (89 | ) | (343 | ) | (302 | ) | (9,056 | ) | |||||||
Comprehensive income | 103,798 | 229,323 | 465,377 | 504,270 | |||||||||||
Net income attributable to noncontrolling interests | (30,477 | ) | (44,331 | ) | (109,323 | ) | (96,953 | ) | |||||||
Comprehensive income attributable to noncontrolling interests | (30,477 | ) | (44,331 | ) | (109,323 | ) | (96,953 | ) | |||||||
Comprehensive income attributable to RenaissanceRe | $ | 73,321 | $ | 184,992 | $ | 356,054 | $ | 407,317 | |||||||
Disclosure regarding net unrealized gains | |||||||||||||||
Total net realized and unrealized holding (gains) losses on investments and net other-than-temporary impairments | $ | (89 | ) | $ | 25 | $ | (302 | ) | $ | (1,508 | ) | ||||
Net realized gains on fixed maturity investments available for sale | — | (368 | ) | — | (7,548 | ) | |||||||||
Change in net unrealized gains on investments | $ | (89 | ) | $ | (343 | ) | $ | (302 | ) | $ | (9,056 | ) |
Nine months ended | |||||||
September 30, 2014 | September 30, 2013 | ||||||
Preference shares | |||||||
Balance – January 1 | $ | 400,000 | $ | 400,000 | |||
Issuance of shares | — | 275,000 | |||||
Repurchase of shares | — | (275,000 | ) | ||||
Balance – September 30 | 400,000 | 400,000 | |||||
Common shares | |||||||
Balance – January 1 | 43,646 | 45,542 | |||||
Repurchase of shares | (4,996 | ) | (1,722 | ) | |||
Exercise of options and issuance of restricted stock awards | 238 | 571 | |||||
Balance – September 30 | 38,888 | 44,391 | |||||
Additional paid-in capital | |||||||
Balance – January 1 | — | — | |||||
Repurchase of shares | (5,359 | ) | 3,019 | ||||
Offering expenses | — | (9,345 | ) | ||||
Change in noncontrolling interests | 1,118 | 622 | |||||
Exercise of options and issuance of restricted stock awards | 4,241 | 5,704 | |||||
Balance – September 30 | — | — | |||||
Accumulated other comprehensive income | |||||||
Balance – January 1 | 4,131 | 13,622 | |||||
Change in net unrealized gains on investments | (302 | ) | (9,056 | ) | |||
Balance – September 30 | 3,829 | 4,566 | |||||
Retained earnings | |||||||
Balance – January 1 | 3,456,607 | 3,043,901 | |||||
Net income | 465,679 | 513,326 | |||||
Net income attributable to noncontrolling interests | (109,323 | ) | (96,953 | ) | |||
Repurchase of shares | (468,200 | ) | (142,208 | ) | |||
Dividends on common shares | (34,834 | ) | (36,956 | ) | |||
Dividends on preference shares | (16,786 | ) | (19,353 | ) | |||
Balance – September 30 | 3,293,143 | 3,261,757 | |||||
Noncontrolling interest | — | 3,720 | |||||
Total shareholders’ equity | $ | 3,735,860 | $ | 3,714,434 |
Nine months ended | |||||||
September 30, 2014 | September 30, 2013 | ||||||
Cash flows provided by operating activities | |||||||
Net income | $ | 465,679 | $ | 513,326 | |||
Adjustments to reconcile net income to net cash provided by operating activities | |||||||
Amortization, accretion and depreciation | 30,270 | 42,423 | |||||
Equity in undistributed earnings of other ventures | (16,519 | ) | (12,048 | ) | |||
Net realized and unrealized (gains) losses on investments | (10,958 | ) | 26,806 | ||||
Net unrealized gains included in net investment income | (2,908 | ) | (33,836 | ) | |||
Net unrealized (gains) losses included in other (loss) income | (264 | ) | 12,782 | ||||
Change in: | |||||||
Premiums receivable | (156,631 | ) | (244,572 | ) | |||
Prepaid reinsurance premiums | (129,846 | ) | (89,258 | ) | |||
Reinsurance recoverable | 21,982 | 43,311 | |||||
Deferred acquisition costs | (48,424 | ) | (51,222 | ) | |||
Reserve for claims and claim expenses | (30,950 | ) | (195,668 | ) | |||
Unearned premiums | 280,384 | 354,560 | |||||
Reinsurance balances payable | 208,133 | 68,569 | |||||
Other | (216,559 | ) | (49,375 | ) | |||
Net cash provided by operating activities | 393,389 | 385,798 | |||||
Cash flows provided by (used in) investing activities | |||||||
Proceeds from sales and maturities of fixed maturity investments trading | 5,896,330 | 6,356,691 | |||||
Purchases of fixed maturity investments trading | (5,843,501 | ) | (6,449,697 | ) | |||
Proceeds from sales and maturities of fixed maturity investments available for sale | 6,076 | 43,564 | |||||
Net purchases of equity investments trading | (33,925 | ) | (33,714 | ) | |||
Net sales (purchases) of short term investments | 21,578 | (118,126 | ) | ||||
Net sales of other investments | 74,706 | 198,101 | |||||
Net sales (purchases) of investments in other ventures | 1,030 | (2,500 | ) | ||||
Net sales (puchases) of other assets | 6,000 | (994 | ) | ||||
Net cash provided by (used in) investing activities | 128,294 | (6,675 | ) | ||||
Cash flows used in financing activities | |||||||
Dividends paid – RenaissanceRe common shares | (34,834 | ) | (36,956 | ) | |||
Dividends paid – preference shares | (16,786 | ) | (19,353 | ) | |||
RenaissanceRe common share repurchases | (475,343 | ) | (140,911 | ) | |||
Net repayment of debt | — | (100,847 | ) | ||||
Redemption of 6.08% Series C preference shares | — | (125,000 | ) | ||||
Redemption of 6.60% Series D preference shares | — | (150,000 | ) | ||||
Issuance of 5.375% Series E preference shares, net of expenses | — | 265,655 | |||||
Net third party redeemable noncontrolling interest share transactions | (107,091 | ) | (103,628 | ) | |||
Net cash used in financing activities | (634,054 | ) | (411,040 | ) | |||
Effect of exchange rate changes on foreign currency cash | 4,886 | 3,366 | |||||
Net decrease in cash and cash equivalents | (107,485 | ) | (28,551 | ) | |||
Net increase in cash and cash equivalents of discontinued operations | — | (9,244 | ) | ||||
Cash and cash equivalents, beginning of period | 408,032 | 304,145 | |||||
Cash and cash equivalents, end of period | $ | 300,547 | $ | 266,350 |
• | Renaissance Reinsurance Ltd. (“Renaissance Reinsurance”), the Company’s principal reinsurance subsidiary, provides property catastrophe and specialty reinsurance coverages to insurers and reinsurers on a worldwide basis. |
• | The Company also manages property catastrophe and specialty reinsurance business written on behalf of joint ventures, which principally include Top Layer Reinsurance Ltd. (“Top Layer Re”), recorded under the equity method of accounting, and DaVinci Reinsurance Ltd. (“DaVinci”). Because the Company owns a noncontrolling equity interest in, but controls a majority of the outstanding voting power of DaVinci’s parent, DaVinciRe Holdings Ltd. (“DaVinciRe”), the results of DaVinci and DaVinciRe are consolidated in the Company’s financial statements. Redeemable noncontrolling interest - DaVinciRe represents the interests of external parties with respect to the net income and shareholders’ equity of DaVinciRe. Renaissance Underwriting Managers, Ltd. (“RUM”), a wholly owned subsidiary, acts as exclusive underwriting manager for these joint ventures in return for fee-based income and profit participation. |
• | RenaissanceRe Syndicate 1458 (“Syndicate 1458”) is the Company’s Lloyd’s syndicate. RenaissanceRe Corporate Capital (UK) Limited (“RenaissanceRe CCL”), a wholly owned subsidiary of RenaissanceRe, is Syndicate 1458’s sole corporate member and RenaissanceRe Syndicate Management Ltd. (“RSML”), a wholly owned subsidiary of RenaissanceRe, is the managing agent for Syndicate 1458. |
• | RenaissanceRe Specialty Risks Ltd. (“RenaissanceRe Specialty Risks”), is a Bermuda-domiciled reinsurance and excess and surplus lines insurance company that is listed on the National Association of Insurance Commissioners’ International Insurance Department’s Quarterly List of Alien Insurers as an eligible surplus lines insurer. RenaissanceRe Underwriting Managers U.S. LLC (“RenaissanceRe Underwriting Managers U.S.”), a specialty reinsurance agency domiciled in Connecticut, provides specialty treaty reinsurance solutions on both a quota share and excess of loss basis; and writes business on behalf of RenaissanceRe Specialty U.S. Ltd. (“RenaissanceRe Specialty U.S.”), a Bermuda-domiciled reinsurer launched in June 2013 which operates subject to U.S. federal income tax, and Syndicate 1458. |
• | Effective January 1, 2013, the Company formed and launched a managed joint venture, Upsilon Reinsurance II Ltd. (“Upsilon Re II”), a Bermuda domiciled special purpose insurer (“SPI”), to provide additional capacity to the worldwide aggregate and per-occurrence primary and retrocessional property catastrophe excess of loss market. Effective December 11, 2013, Upsilon Re II was renamed Upsilon Reinsurance Fund Opportunities Ltd. (“Upsilon RFO”). Upsilon RFO is considered a variable interest entity (“VIE”) and the Company is considered the primary beneficiary. As a result, Upsilon RFO is consolidated by the Company and all significant inter-company transactions have been eliminated. |
• | RenaissanceRe Medici Fund Ltd. (“Medici”) is an exempted fund, incorporated under the laws of Bermuda. Medici’s objective is to seek to invest substantially all of its assets in various insurance-based investment instruments that have returns primarily tied to property catastrophe risk. Third-party investors have subscribed for a portion of the participating, non-voting common shares of |
• | On August 30, 2013, RenaissanceRe entered into a purchase agreement with a subsidiary of Munich-American Holding Corporation (together with applicable affiliates, “Munich”) to sell the Company’s U.S.-based weather and weather-related energy risk management unit, which principally included RenRe Commodity Advisors LLC (“RRCA”), Renaissance Trading Ltd. (“Renaissance Trading”) and RenRe Energy Advisors Ltd. (collectively referred to as “REAL”). REAL offered certain derivative-based risk management products primarily to address weather and energy risk and engaged in hedging and trading activities related to those transactions. On October 1, 2013, RenaissanceRe closed the sale of REAL to Munich. In the third quarter of 2013, the Company classified the assets and liabilities associated with this transaction as held for sale. The financial results for these operations have been presented in the Company’s consolidated financial statements as “discontinued operations” for all periods presented. Refer to “Note 3. Discontinued Operations”, for more information. |
Three months ended | Nine months ended | ||||||||||||||||
September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | ||||||||||||||
Revenues | |||||||||||||||||
Net investment (loss) income | $ | — | $ | (3 | ) | $ | — | $ | 1,150 | ||||||||
Net foreign exchange (losses) gains | — | (140 | ) | — | 849 | ||||||||||||
Other (loss) income | — | (1,001 | ) | — | 9,471 | ||||||||||||
Net realized and unrealized losses on investments | — | (5 | ) | — | (18 | ) | |||||||||||
Total revenues | — | (1,149 | ) | — | 11,452 | ||||||||||||
Expenses | |||||||||||||||||
Operational expenses | — | 30 | — | 89 | |||||||||||||
Corporate expenses | — | (2 | ) | — | 104 | ||||||||||||
Total expenses | — | 28 | — | 193 | |||||||||||||
Loss on sale of REAL | — | (8,770 | ) | — | (8,770 | ) | |||||||||||
(Loss) income before taxes | — | (9,947 | ) | — | 2,489 | ||||||||||||
Income tax expense | — | 168 | — | (67 | ) | ||||||||||||
(Loss) income from discontinued operations | $ | — | $ | (9,779 | ) | $ | — | $ | 2,422 | ||||||||
September 30, 2014 | December 31, 2013 | ||||||||
U.S. treasuries | $ | 1,636,326 | $ | 1,352,413 | |||||
Agencies | 120,025 | 186,050 | |||||||
Non-U.S. government (Sovereign debt) | 282,326 | 334,580 | |||||||
Non-U.S. government-backed corporate | 141,159 | 237,479 | |||||||
Corporate | 1,572,168 | 1,803,415 | |||||||
Agency mortgage-backed | 320,584 | 336,661 | |||||||
Non-agency mortgage-backed | 252,241 | 243,795 | |||||||
Commercial mortgage-backed | 397,685 | 303,214 | |||||||
Asset-backed | 28,252 | 11,429 | |||||||
Total fixed maturity investments trading | $ | 4,750,766 | $ | 4,809,036 | |||||
Included in Accumulated Other Comprehensive Income | |||||||||||||||||||||
September 30, 2014 | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Non-Credit Other-Than- Temporary Impairments (1) | ||||||||||||||||
Agency mortgage-backed | $ | 4,174 | $ | 380 | $ | — | $ | 4,554 | $ | — | |||||||||||
Non-agency mortgage-backed | 9,999 | 2,218 | (3 | ) | 12,214 | (677 | ) | ||||||||||||||
Commercial mortgage-backed | 7,294 | 656 | — | 7,950 | — | ||||||||||||||||
Asset-backed | 3,197 | 154 | — | 3,351 | — | ||||||||||||||||
Total fixed maturity investments available for sale | $ | 24,664 | $ | 3,408 | $ | (3 | ) | $ | 28,069 | $ | (677 | ) | |||||||||
Included in Accumulated Other Comprehensive Income | |||||||||||||||||||||
December 31, 2013 | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Non-Credit Other-Than- Temporary Impairments (1) | ||||||||||||||||
Agency mortgage-backed | $ | 4,880 | $ | 378 | $ | (11 | ) | $ | 5,247 | $ | — | ||||||||||
Non-agency mortgage-backed | 11,735 | 2,414 | (6 | ) | 14,143 | (742 | ) | ||||||||||||||
Commercial mortgage-backed | 10,052 | 970 | — | 11,022 | — | ||||||||||||||||
Asset-backed | 3,606 | 223 | — | 3,829 | — | ||||||||||||||||
Total fixed maturity investments available for sale | $ | 30,273 | $ | 3,985 | $ | (17 | ) | $ | 34,241 | $ | (742 | ) | |||||||||
(1) | Represents the non-credit component of other-than-temporary impairments recognized in accumulated other comprehensive income adjusted for subsequent sales of securities. It does not include the change in fair value subsequent to the impairment measurement date. |
Trading | Available for Sale | Total Fixed Maturity Investments | |||||||||||||||||||||||
September 30, 2014 | Amortized Cost | Fair Value | Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||||||||||||||||
Due in less than one year | $ | 97,830 | $ | 97,868 | $ | — | $ | — | $ | 97,830 | $ | 97,868 | |||||||||||||
Due after one through five years | 2,951,631 | 2,949,329 | — | — | 2,951,631 | 2,949,329 | |||||||||||||||||||
Due after five through ten years | 595,874 | 593,633 | — | — | 595,874 | 593,633 | |||||||||||||||||||
Due after ten years | 108,080 | 111,174 | — | — | 108,080 | 111,174 | |||||||||||||||||||
Mortgage-backed | 953,480 | 970,510 | 21,467 | 24,718 | 974,947 | 995,228 | |||||||||||||||||||
Asset-backed | 28,166 | 28,252 | 3,197 | 3,351 | 31,363 | 31,603 | |||||||||||||||||||
Total | $ | 4,735,061 | $ | 4,750,766 | $ | 24,664 | $ | 28,069 | $ | 4,759,725 | $ | 4,778,835 | |||||||||||||
September 30, 2014 | December 31, 2013 | ||||||||
Financials | $ | 199,798 | $ | 152,905 | |||||
Communications and technology | 32,377 | 4,300 | |||||||
Industrial, utilities and energy | 30,347 | 25,350 | |||||||
Consumer | 18,796 | 44,115 | |||||||
Healthcare | 16,396 | 15,340 | |||||||
Basic materials | 4,000 | 12,766 | |||||||
Total | $ | 301,714 | $ | 254,776 | |||||
Three months ended | Nine months ended | ||||||||||||||||
September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | ||||||||||||||
Fixed maturity investments | $ | 24,519 | $ | 24,423 | $ | 74,751 | $ | 71,148 | |||||||||
Short term investments | 251 | 563 | 727 | 1,318 | |||||||||||||
Equity investments | 736 | 706 | 2,311 | 1,050 | |||||||||||||
Other investments | |||||||||||||||||
Hedge funds and private equity investments | (3,320 | ) | 14,179 | 17,337 | 31,296 | ||||||||||||
Other | 5,547 | 22,735 | 11,558 | 32,874 | |||||||||||||
Cash and cash equivalents | 116 | 47 | 300 | 108 | |||||||||||||
27,849 | 62,653 | 106,984 | 137,794 | ||||||||||||||
Investment expenses | (2,908 | ) | (2,722 | ) | (8,554 | ) | (8,498 | ) | |||||||||
Net investment income | $ | 24,941 | $ | 59,931 | $ | 98,430 | $ | 129,296 | |||||||||
Three months ended | Nine months ended | ||||||||||||||||
September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | ||||||||||||||
Gross realized gains | $ | 7,962 | $ | 8,813 | $ | 33,595 | $ | 60,437 | |||||||||
Gross realized losses | (2,720 | ) | (22,241 | ) | (10,871 | ) | (41,396 | ) | |||||||||
Net realized gains on fixed maturity investments | 5,242 | (13,428 | ) | 22,724 | 19,041 | ||||||||||||
Net unrealized (losses) gains on fixed maturity investments trading | (36,600 | ) | 33,405 | 21,200 | (85,338 | ) | |||||||||||
Net realized and unrealized (losses) gains on investments-related derivatives | (1,868 | ) | 3,557 | (19,651 | ) | 24,488 | |||||||||||
Net realized gains on equity investments trading | 3,523 | 560 | 8,578 | 18,195 | |||||||||||||
Net unrealized (losses) gains on equity investments trading | (1,394 | ) | 4,378 | (21,893 | ) | (3,174 | ) | ||||||||||
Net realized and unrealized (losses) gains on investments | $ | (31,097 | ) | $ | 28,472 | $ | 10,958 | $ | (26,788 | ) | |||||||
Three months ended September 30, 2014 | |||||||||||||
Investments in other ventures | Fixed maturity investments available for sale | Total | |||||||||||
Beginning balance | $ | 211 | $ | 3,707 | $ | 3,918 | |||||||
Other comprehensive income (loss) before reclassifications | 213 | (302 | ) | (89 | ) | ||||||||
Ending balance | $ | 424 | $ | 3,405 | $ | 3,829 | |||||||
Nine months ended September 30, 2014 | |||||||||||||
Investments in other ventures | Fixed maturity investments available for sale | Total | |||||||||||
Beginning balance | $ | 163 | $ | 3,968 | $ | 4,131 | |||||||
Other comprehensive income (loss) before reclassifications | 261 | (563 | ) | (302 | ) | ||||||||
Ending balance | $ | 424 | $ | 3,405 | $ | 3,829 | |||||||
Three months ended September 30, 2013 | |||||||||||||
Investments in other ventures | Fixed maturity investments available for sale | Total | |||||||||||
Beginning balance | $ | 218 | $ | 4,691 | $ | 4,909 | |||||||
Other comprehensive (loss) income before reclassifications | (91 | ) | 116 | 25 | |||||||||
Amounts reclassified from accumulated other comprehensive income by statement of operations line item: | |||||||||||||
Realized gains reclassified from accumulated other comprehensive income to net realized and unrealized gains (losses) on investments | — | (368 | ) | (368 | ) | ||||||||
Net current-period other comprehensive loss | (91 | ) | (252 | ) | (343 | ) | |||||||
Ending balance | $ | 127 | $ | 4,439 | $ | 4,566 | |||||||
Nine months ended September 30, 2013 | |||||||||||||
Investments in other ventures | Fixed maturity investments available for sale | Total | |||||||||||
Beginning balance | $ | 1,625 | $ | 11,997 | $ | 13,622 | |||||||
Other comprehensive loss before reclassifications | (1,498 | ) | (10 | ) | (1,508 | ) | |||||||
Amounts reclassified from accumulated other comprehensive income by statement of operations line item: | |||||||||||||
Realized gains reclassified from accumulated other comprehensive income to net realized and unrealized gains (losses) on investments | — | (7,548 | ) | (7,548 | ) | ||||||||
Net current-period other comprehensive loss | (1,498 | ) | (7,558 | ) | (9,056 | ) | |||||||
Ending balance | $ | 127 | $ | 4,439 | $ | 4,566 | |||||||
Less than 12 Months | 12 Months or Greater | Total | |||||||||||||||||||||||
At September 30, 2014 | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | |||||||||||||||||||
Non-agency mortgage-backed | $ | — | $ | — | $ | 73 | $ | (3 | ) | $ | 73 | $ | (3 | ) | |||||||||||
Total | $ | — | $ | — | $ | 73 | $ | (3 | ) | $ | 73 | $ | (3 | ) | |||||||||||
Less than 12 Months | 12 Months or Greater | Total | |||||||||||||||||||||||
December 31, 2013 | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | |||||||||||||||||||
Agency mortgage-backed | $ | 726 | $ | (11 | ) | $ | — | $ | — | $ | 726 | $ | (11 | ) | |||||||||||
Non-agency mortgage-backed | — | — | 89 | (6 | ) | 89 | (6 | ) | |||||||||||||||||
Commercial mortgage-backed | 39 | — | — | — | 39 | — | |||||||||||||||||||
Total | $ | 765 | $ | (11 | ) | $ | 89 | $ | (6 | ) | $ | 854 | $ | (17 | ) | ||||||||||
Three months ended | Nine months ended | ||||||||||||||||
September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | ||||||||||||||
Beginning balance | $ | 529 | $ | 791 | $ | 561 | $ | 838 | |||||||||
Reductions: | |||||||||||||||||
Securities sold during the period | (15 | ) | (38 | ) | (47 | ) | (85 | ) | |||||||||
Ending balance | $ | 514 | $ | 753 | $ | 514 | $ | 753 | |||||||||
• | Fair values determined by Level 1 inputs utilize unadjusted quoted prices obtained from active markets for identical assets or liabilities for which the Company has access. The fair value is determined by multiplying the quoted price by the quantity held by the Company; |
• | Fair values determined by Level 2 inputs utilize inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets and liabilities in active markets, and inputs other than quoted prices that are observable for the asset or liability, such as interest rates and yield curves that are observable at commonly quoted intervals, broker quotes and certain pricing indices; and |
• | Level 3 inputs are based all or in part on significant unobservable inputs for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. In these cases, significant management assumptions can be used to establish management’s best estimate of the assumptions used by other market participants in determining the fair value of the asset or liability. |
At September 30, 2014 | Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||
Fixed maturity investments | |||||||||||||||||
U.S. treasuries | $ | 1,636,326 | $ | 1,636,326 | $ | — | $ | — | |||||||||
Agencies | 120,025 | — | 120,025 | — | |||||||||||||
Non-U.S. government (Sovereign debt) | 282,326 | — | 282,326 | — | |||||||||||||
Non-U.S. government-backed corporate | 141,159 | — | 141,159 | — | |||||||||||||
Corporate | 1,572,168 | — | 1,556,232 | 15,936 | |||||||||||||
Agency mortgage-backed | 325,138 | — | 325,138 | — | |||||||||||||
Non-agency mortgage-backed | 264,455 | — | 264,455 | — | |||||||||||||
Commercial mortgage-backed | 405,635 | — | 405,635 | — | |||||||||||||
Asset-backed | 31,603 | — | 31,603 | — | |||||||||||||
Total fixed maturity investments | 4,778,835 | 1,636,326 | 3,126,573 | 15,936 | |||||||||||||
Short term investments | 1,031,143 | — | 1,031,143 | — | |||||||||||||
Equity investments trading | 301,714 | 301,714 | — | — | |||||||||||||
Other investments | |||||||||||||||||
Private equity partnerships | 300,800 | — | — | 300,800 | |||||||||||||
Catastrophe bonds | 179,246 | — | 179,246 | — | |||||||||||||
Senior secured bank loan fund | 18,723 | — | — | 18,723 | |||||||||||||
Hedge funds | 2,718 | — | — | 2,718 | |||||||||||||
Total other investments | 501,487 | — | 179,246 | 322,241 | |||||||||||||
Other assets and (liabilities) | |||||||||||||||||
Assumed and ceded (re)insurance contracts | (7,281 | ) | — | — | (7,281 | ) | |||||||||||
Derivatives (1) | (1,468 | ) | 479 | (1,957 | ) | 10 | |||||||||||
Other | (8,523 | ) | — | (8,523 | ) | — | |||||||||||
Total other assets and (liabilities) | (17,272 | ) | 479 | (10,480 | ) | (7,271 | ) | ||||||||||
$ | 6,595,907 | $ | 1,938,519 | $ | 4,326,482 | $ | 330,906 | ||||||||||
December 31, 2013 | Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||
Fixed maturity investments | |||||||||||||||||
U.S. treasuries | $ | 1,352,413 | $ | 1,352,413 | $ | — | $ | — | |||||||||
Agencies | 186,050 | — | 186,050 | — | |||||||||||||
Non-U.S. government (Sovereign debt) | 334,580 | — | 334,580 | — | |||||||||||||
Non-U.S. government-backed corporate | 237,479 | — | 237,479 | — | |||||||||||||
Corporate | 1,803,415 | — | 1,775,835 | 27,580 | |||||||||||||
Agency mortgage-backed | 341,908 | — | 341,908 | — | |||||||||||||
Non-agency mortgage-backed | 257,938 | — | 257,938 | — | |||||||||||||
Commercial mortgage-backed | 314,236 | — | 314,236 | — | |||||||||||||
Asset-backed | 15,258 | — | 15,258 | — | |||||||||||||
Total fixed maturity investments | 4,843,277 | 1,352,413 | 3,463,284 | 27,580 | |||||||||||||
Short term investments | 1,044,779 | — | 1,044,779 | — | |||||||||||||
Equity investments trading | 254,776 | 254,776 | — | — | |||||||||||||
Other investments | |||||||||||||||||